Licenses on promising compounds or compound classes will be proposed to the pharmaceutical industry. In this way, the SILVER consortium will be well placed to play a major role in contributing to the international effort to develop strategies to improve world health.

The Technology Transfer Platform (TTP) is the unique entry point to create relationships between the SILVER consortium and external end-users. The TTP gives access to confidential results for possible patents, collaboration or license agreements... Read more

The research leading to these results has received funding from the European Union Seventh Programme (FP7 2007/2013) under grant agreement n°260644-SILVER